Send to

Choose Destination
See comment in PubMed Commons below
Biochem Biophys Res Commun. 2011 Jan 21;404(3):882-6. doi: 10.1016/j.bbrc.2010.12.080. Epub 2010 Dec 21.

O-GlcNAcylation increases non-amyloidogenic processing of the amyloid-β precursor protein (APP).

Author information

  • 1Department of Neurochemistry, Stockholm University, SE-10691 Stockholm, Sweden.


The amyloid-β precursor protein (APP) was shown to be O-GlcNAcylated 15 years ago, but the effect of this modification on APP processing and formation of the Alzheimer's disease associated amyloid-β (Aβ) peptide has so far not been investigated. Here, we demonstrate with pharmacological tools or siRNA that O-GlcNAcase and O-GlcNAc transferase regulate the level of O-GlcNAcylated APP. We also show that O-GlcNAcylation increases non-amyloidogenic α-secretase processing, resulting in increased levels of the neuroprotective sAPPα fragment and decreased Aβ secretion. Our results implicate O-GlcNAcylation as a potential therapeutic target for Alzheimer's disease.

Copyright © 2010 Elsevier Inc. All rights reserved.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk